Terms: = Prostate cancer AND MLLT1, ENL, 4298, ENSG00000130382, Q03111, YEATS1, LTG19 AND Treatment
7 results:
1. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer.
Kim S; Kong JH; Lee Y; Lee JY; Kang TW; Kong TH; Kim MH; You SH
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012817. PubMed ID: 36884035
[TBL] [Abstract] [Full Text] [Related]
2. Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.
Bandini M; Pompe RS; Marchioni M; Zaffuto E; Gandaglia G; Fossati N; Cindolo L; Montorsi F; Briganti A; Saad F; Karakiewicz PI
Int Urol Nephrol; 2018 Jan; 50(1):71-78. PubMed ID: 29129028
[TBL] [Abstract] [Full Text] [Related]
3. Enterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment.
Di Y; Ji S; Wolf P; Krol ES; Alcorn J
AAPS PharmSciTech; 2017 Aug; 18(6):2336-2345. PubMed ID: 28116598
[TBL] [Abstract] [Full Text] [Related]
4. Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth.
Zhou Y; Liu YE; Cao J; Zeng G; Shen C; Li Y; Zhou M; Chen Y; Pu W; Potters L; Shi YE
Clin Cancer Res; 2009 Aug; 15(16):5161-9. PubMed ID: 19671865
[TBL] [Abstract] [Full Text] [Related]
5. Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro.
McCann MJ; Gill CI; Linton T; Berrar D; McGlynn H; Rowland IR
Mol Nutr Food Res; 2008 May; 52(5):567-80. PubMed ID: 18398867
[TBL] [Abstract] [Full Text] [Related]
6. Thalidomide: a review of approved and investigational uses.
Matthews SJ; McCoy C
Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
[TBL] [Abstract] [Full Text] [Related]
7. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract] [Full Text] [Related]
